CBIZ (CBZ) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Announced agreement to acquire Marcum for $2.3B, expected to close in Q4 2024, creating a combined entity with $2.8B in revenue, over 10,000 professionals, and 135,000+ clients, positioning as the 7th largest U.S. accounting services provider.
Q2 and first-half 2024 revenue grew 5.4% and 7.2% year-over-year, with same-unit revenue up 2.8% in Q2 and 4.4% in the first half; acquisitions contributed 2.6% and 2.7% respectively.
Q2 net income was $19.8M, down 26.3% year-over-year, with GAAP EPS falling 26.4% due to $6.7M in Marcum transaction-related expenses and a rare P&C team exit impacting EPS by $0.03.
The business model emphasizes high recurring revenue (~75%), strong client retention (~90%), and a broad geographic footprint.
Business climate remained stable, but some project-based and discretionary services experienced delays due to economic uncertainty and the election year.
Financial highlights
Q2 2024 revenue was $420.0M, gross margin $53.6M (13.3%), and operating income $31.6M (7.5%).
Q2 same-unit revenue grew 2.8%, with acquisitions contributing 2.6%; first-half same-unit revenue up 4.4%, acquisitions added 2.7%.
Financial Services Q2 revenue up 6.3% (same-unit up 3.0%); Benefits & Insurance Q2 revenue up 1.6% (same-unit up 0.7%).
Q2 and first-half included $6.7M in Marcum transaction costs, excluded from adjusted EPS.
Net cash provided by operating activities for H1 2024 was $24.4M, down from $29.7M in H1 2023.
Outlook and guidance
Full-year 2024 revenue expected to grow 7%-9%; GAAP EPS expected to increase 6%-8% over 2023 ($2.39); adjusted EPS to rise 10%-12% over 2023 ($2.41), with a $0.06 per share reduction due to the P&C incident.
Effective tax rate projected at ~28% for 2024; diluted share count expected: 50M-50.5M.
Marcum transaction expected to close in Q4 2024; 2025 guidance to be provided post-close.
Guidance excludes the impact of the Marcum acquisition, with updates expected after closing.
Second-half 2024 expected to show stronger year-over-year growth as headwinds subside.
Latest events from CBIZ
- Revenue up 52% to $2.8B in 2025, with 2026 targeting 2–5% growth and higher free cash flow.CBZ
Q4 202525 Feb 2026 - Balanced organic and acquisition-driven growth, high retention, and margin expansion drive outperformance.CBZ
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q3 adjusted EPS up 27.3% and Marcum acquisition completed, boosting scale and leverage.CBZ
Q3 202418 Jan 2026 - Acquisition of Marcum creates a top-7 firm, boosting scale, recurring revenue, and growth prospects.CBZ
Sidoti Small-Cap Virtual Investor Conference11 Jan 2026 - Q1 2025 revenue up 69.5% to $838M, adjusted EBITDA doubled, Marcum integration on track.CBZ
Q1 202525 Dec 2025 - 2025 guidance: $2.90–$2.95B revenue, $3.60–$3.65 adjusted EPS, $450M–$456M EBITDA.CBZ
Q4 202421 Dec 2025 - Shareholders to vote on $2.3B Marcum acquisition, with major stock issuance and board changes.CBZ
Proxy Filing1 Dec 2025 - Proxy covers director elections, auditor ratification, say-on-pay, and robust governance disclosures.CBZ
Proxy Filing1 Dec 2025 - Shareholders to vote on a $2.3B merger with Marcum LLP, adding 22% new shares and board representation.CBZ
Proxy Filing1 Dec 2025